From GlobeNewswire: 2025-03-21 06:00:00

SANUWAVE Health, Inc. reported record revenues of $10.3 million in Q4 2024, up 47% from Q4 2023. Full year 2024 revenues reached $32.6 million, a 60% increase from 2023. Q4 2024 gross margin was 77.9%, while full year 2024 gross margin was 75.2%. Operating income for Q4 2024 was $2.5 million and $5.4 million for the full year.

The Company projects revenue growth of 45-55% for Q1 2025 compared to Q1 2024. Full year 2025 revenue guidance is set at $48-50 million, representing a 47-53% increase from 2024. SANUWAVE continues to focus on profitable growth and managing expenses to drive positive cash flows.

CEO Morgan Frank expressed satisfaction with the record-breaking results in Q4 2024 and the transformational year for SANUWAVE. The Company’s revenue pipeline is strong, with a sales force and strategy in place to manage customer engagement effectively. 2025 is poised to be a breakout year following the simplification of the capital structure and listing on the Nasdaq Global Market. SANUWAVE Health announced a business update conference call on March 21, 2025, at 8:30 a.m. EST. Information and materials can be found on the company’s website. Telephone access numbers for the call are Toll Free: 1-800-245-3047 and Toll/International: 1-203-518-9765 with Conference ID: SANUWAVE or click the provided link for instant access.

A replay of the conference call will be available until April 11, 2025, with Toll-Free: 1-844-512-2921 and Toll/International: 1-412-317-6671. The Replay Access ID is 11157832. SANUWAVE focuses on non-invasive medical systems for skin, musculoskeletal tissue, and vascular structures. Their wound care products aid in natural healing processes using patented energy transfer technologies. They use non-GAAP financial measures like EBITDA and Adjusted EBITDA to assess operating performance.

Forward-looking statements in the press release outline future financial results and business development plans. Risks include regulatory oversight, capital management, and competition. Actual results may differ from projections due to uncertainties. SANUWAVE’s periodic filings with the SEC offer detailed information on risks, assumptions, and factors affecting performance and financial condition. 1. The stock market reached record highs today, with the Dow Jones Industrial Average closing at 30,000 for the first time ever. This milestone comes as investors remain optimistic about a potential COVID-19 vaccine and economic recovery.

2. In other news, the latest unemployment numbers show a decrease in jobless claims, with 712,000 Americans filing for benefits last week. While this is a positive sign, experts warn that the labor market still faces challenges as the pandemic continues.

3. On the international front, tensions are rising between Iran and Israel after the assassination of a top Iranian nuclear scientist. The Iranian government has accused Israel of being behind the attack, further escalating the already strained relationship between the two countries.

4. In technology news, Apple has announced plans to release a new line of Mac computers powered by its own custom-designed chips. This move away from Intel processors marks a significant shift for the tech giant and is expected to improve performance and efficiency in future Mac devices.



Read more at GlobeNewswire:: SANUWAVE Announces Record Quarterly Revenues: Q4 FY2024